Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide Vaginal Ring for Endometriosis Lesions
NCT03749109Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in endometriosis and adenomyosis comparing Quinagolide 1080 µg with Placebo (2 arms). Primary endpoint: Changes in the Sizes (mm) of Endometrioma, Deep Infiltrating Endometriosis (DIE) and Adenomyosis Lesions Summed by Type on Magnetic Resonance (MR) Images. Started Aug 2019; status: completed.
02
Drugs
quinagolide
03
Conditions
endometriosisadenomyosis
Beyond the preview
Go deeper on NCT03749109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749109.